1. Field of Use
Embodiments of the present invention relate generally to the treatment of wounds using negative pressure wound therapy, and more specifically to an improved apparatus and method thereof to manage open abdominal wounds.
2. Description of Related Art
The treatment of open or chronic wounds by means of applying negative pressure to the site of the wound, where the wounds are too large to spontaneously close or otherwise fail to heal is well known in the art. Negative pressure wound treatment systems currently known in the art commonly involve placing a cover that is impermeable to liquids over the wound, using various mechanisms to seal the cover to the tissue of the patient surrounding the wound, and connecting a source of negative pressure (such as a vacuum pump) to the cover whereby an area of negative pressure is created under the cover in the area of the wound.
Embodiments of the invention disclosed herein are directed to a reduced pressure appliance and methods of treatment using a reduced pressure appliance, and may be useful in the treatment of wounds using reduced pressure.
Certain embodiments of the invention are directed to improved methods of treating abdominal wounds or incisions with negative pressure. For example and for illustrative purposes only, some embodiments employ a porous pad with detachable sections permitting desired sizing of the pad to the wound site. Sizing of the foam pad may in some embodiments be performed in a dimensionally-independent manner so that, for example, the width and/or length may be modified independently of each other. Further embodiments also provide for a wound contact layer to be placed in contact with the wound site, where the wound contact layer is preferably minimally or non-adherent to the wound site and provided with slits or other openings for the removal of wound exudate or fluids and the application of negative pressure to the wound site.
Certain embodiments provide for a negative pressure treatment system comprising a wound contact layer placed over the wound, a porous pad configured to be sized and positioned over the wound contact layer, a flexible drape configured to be placed above the wound and sealed to the skin surrounding the wound, and which further comprises a conduit configured to deliver negative pressure to the wound through an aperture in the flexible drape and through the porous pad and wound contact layer.
In a preferred embodiment, a porous pad is provided for the treatment of wounds with negative pressure, wherein the porous pad is comprised of a porous material suitable for channeling wound exudate from a wound site to a source of negative pressure. The porous pad preferably comprises a generally planar shape with a thickness less than its width and length, and preferably comprises at least one cut extending through a least a portion of the thickness of the pad, whereby the cut defines a pad section detachable from the remainder of the pad so as to permit modification of the size of the pad (for example its length and/or width). In certain embodiments, the cuts may be comprised of arcuate and/or elliptical cuts, and may further comprise additional inner and outer cuts. In further embodiments, additional intermediate cuts may also be present.
In another preferred embodiment, a system for the treatment of a wound site comprises a wound contact layer provided with openings for channeling wound exudate and distributing negative pressure, a generally planar porous pad suitable for transmitting negative pressure to a wound site and comprising at least one cut extending through a portion of the pad's thickness so as to define a detachable pad, a flexible drape, a conduit, and a source of negative pressure configured to deliver negative pressure through the conduit to the wound site.
In yet another preferred embodiment, a method of treating a wound site using negative pressure may comprise placing a wound contact layer onto the wound site; placing a porous pad over the wound contact layer, where the porous pad is perforated to allow removal of pad portions so as to permit sizing of the pad in a dimensionally-independent manner to fit the wound site; sealing the wound site with a flexible drape configured to be positioned over the wound and sealed to the skin surrounding the wound; connecting a source of negative pressure to the wound site; and maintaining the application of negative pressure until the wound site has healed appropriately.
Preferred embodiments disclosed herein relate to wound therapy for a human or animal body. Therefore, any reference to a wound herein can refer to a wound on a human or animal body, and any reference to a body herein can refer to a human or animal body. The term “wound” as used herein, in addition to having its broad ordinary meaning, includes any body part of a patient that may be treated using reduced pressure. Wounds and/or wound sites include, but are not limited to, open wounds, pressure sores, ulcers and burns. Open wounds and/or wound sites may also include incisions (e.g., abdominal incisions) or other openings, tears, or fistulas, for example, in the abdominal or peritoneal cavity. Treatment of such wounds can be performed using negative pressure wound therapy, wherein a reduced or negative pressure can be applied to the wound to facilitate and promote healing of the wound. It will also be appreciated that the negative pressure systems and methods as disclosed herein may be applied to other parts of the body, and are not necessarily limited to treatment of wounds.
Turning to
In cases where there is a wound, particularly in the abdomen, management of possible complications relating to the exposure of organs and the peritoneal space is desired, whether or not the wound is to remain open or if it will be closed. Therapy, preferably using the application of negative pressure, can be targeted to minimize the risk of infection, while promoting tissue viability and the removal of deleterious substances from the wound site. The application of reduced or negative pressure to a wound site has been found to generally promote faster healing, increased blood flow, decreased bacterial burden, increased rate of granulation tissue formation, to stimulate the proliferation of fibroblasts, stimulate the proliferation of endothelial cells, close chronic open wounds, inhibit burn penetration, and/or enhance flap and graft attachment, among other things. It has also been reported that wounds that have exhibited positive response to treatment by the application of negative pressure include infected open wounds, decubitus ulcers, dehisced incisions, partial thickness burns, and various lesions to which flaps or grafts have been attached. Consequently, the application of negative pressure to a wound site 110 can be beneficial to a patient.
Accordingly, certain embodiments provide for a wound contact layer 105 to be placed over the wound site 110. Preferably, the wound contact layer 105 can be a thin, flexible material which will not adhere to the wound site or the exposed viscera in close proximity. For example, polymers such as polyurethane, polyethylene, polytetrafluoroethylene, or blends thereof may be used. In one embodiment, the wound contact layer is permeable. For example, the wound contact layer 105 can be provided with openings, such as holes, slits, or channels, to allow the removal of fluids from the wound site 110 or the transmittal of negative pressure to the wound site 110. Additional embodiments of the wound contact layer 105 are described in further detail below.
Certain embodiments of the negative pressure treatment system 101 may also use a porous pad 103, which can be disposed over the wound contact layer 105. This pad 103 can be constructed from a porous material, for example foam, that is soft, resiliently flexible, and generally conformable to the wound site 110. Such a foam can include an open-celled and reticulated foam made, for example, of a polymer. Suitable foams include foams composed of, for example, polyurethane, silicone, and polyvinyl alcohol. Preferably, this pad 103 can channel wound exudate and other fluids through itself when negative pressure is applied to the wound. Some pads 103 may include preformed channels or openings for such purposes. In certain embodiments, the pad 103 may have a thickness between about one inch and about two inches. The pad may also have a length of between about 16 and 17 inches, and a width of between about 11 and 12 inches. In other embodiments, the thickness, width, and/or length can have other suitable values. Other aspects of the pad 103 are discussed in further detail below.
Preferably, a drape 107 is used to seal the wound site 110. The drape 107 can be at least partially liquid impermeable, such that at least a partial negative pressure may be maintained at the wound site. Suitable materials for the drape 107 include, without limitation, synthetic polymeric materials that do not significantly absorb aqueous fluids, including polyolefins such as polyethylene and polypropylene, polyurethanes, polysiloxanes, polyamides, polyesters, and other copolymers and mixtures thereof. The materials used in the drape may be hydrophobic or hydrophilic. Examples of suitable materials include Transeal® available from DeRoyal and Op Site® available from Smith & Nephew. In order to aid patient comfort and avoid skin maceration, the drapes in certain embodiments are at least partly breathable, such that water vapor is able to pass through without remaining trapped under the dressing. An adhesive layer may be provided on at least a portion the underside of the drape 107 to secure the drape to the skin of the patient, although certain embodiments may instead use a separate adhesive or adhesive strip. Optionally, a release layer may be disposed over the adhesive layer to protect it prior to use and to facilitate handling the drape 107; in some embodiments, the release layer may be composed of multiple sections.
The negative pressure system 101 can be connected to a source of negative pressure, for example a pump 114. One example of a suitable pump is the Renasys EZ pump available from Smith & Nephew. The drape 107 may be connected to the source of negative pressure 114 via a conduit 112. The conduit 112 may be connected to a port 113 situated over an aperture 109 in the drape 107, or else the conduit 112 may be connected directly through the aperture 109 without the use of a port. In a further alternative, the conduit may pass underneath the drape and extend from a side of the drape. U.S. Pat. No. 7,524,315 discloses other similar aspects of negative pressure systems and is hereby incorporated by reference in its entirety and should be considered a part of this specification.
In many applications, a container or other storage unit 115 may be interposed between the source of negative pressure 114 and the conduit 112 so as to permit wound exudate and other fluids removed from the wound site to be stored without entering the source of negative pressure. Certain types of negative pressure sources—for example, peristaltic pumps—may also permit a container 115 to be placed after the pump 114. Some embodiments may also use a filter to prevent fluids, aerosols, and other microbial contaminants from leaving the container 115 and/or entering the source of negative pressure 114. Further embodiments may also include a shut-off valve or occluding hydrophobic and/or oleophobic filter in the container to prevent overflow; other embodiments may include sensing means, such as capacitative sensors or other fluid level detectors that act to stop or shut off the source of negative pressure should the level of fluid in the container be nearing capacity. At the pump exhaust, it may also be preferable to provide an odor filter, such as an activated charcoal canister.
With reference to
In one embodiment, the pad 103 has a substantially rectangular shape having a length L, a width W, and a thickness T defined about a major axis X, a minor axis Y, and a vertical axis Z, and has four rounded corners. A first series of arcuate outer cuts 202 may be formed in the pad in an elliptical shape. In the illustrated embodiment, there are four outer cuts 202a, 202b, 202c and 202d, each positioned in one of the quadrants defined by the axes X and Y, with four bridge portions 206 positioned at opposite ends along the major and minor axes. Interior to the outer cuts 202 are a series of arcuate inner cuts 210 also having an elliptical shape similarly shaped to the series of arcuate outer cuts 202. As illustrated, in one embodiment there are four inner cuts 210a, 210b, 210c, 210d also each positioned in one of the quadrants defined by the axes X and Y, with four bridge portions 222 positioned at opposite ends along the major and minor axes.
Located between the outer and inner cuts 202 and 210 are a series of intermediate cuts 204 and 208. From the top view perspective of
Advantageously, cuts made on the pad 103 can be used to selectively size the pad 103 to the wound site in which the pad 103 is to be placed. For example, the pad 103 can be sized by removing detachable sections from the pad 103, for example, outer section 218 that surrounds outer cuts 202, inner sections 212a, 212b located between the outer cuts 202 and intermediate cuts 204a and 204b, and inner sections 214a, 214b between the outer cuts 202 and intermediate cuts 208. Although additional and different cuts from the cuts 202, 204, 208, and 210 may be made on the pad 103, these cuts represent examples of types and locations of cuts that can be used to size a pad in a dimensionally-independent manner. Types of cuts that can be made on the pad 103 include, for example, arcuate, circular, ovoid, zigzag, and/or linear cuts. Further, although the cuts shown here are along the length L and width W of the pad, similar cuts may be made along the thickness T of pad 103, such that a thinner pad can be used in a wound site. Cuts may also be made at an angle not aligned with either of the X, Y, or Z axes, for example diagonally across the pad 103.
In use, the pad 103 may be too large for the wound site 110, and may need to be sized by removing the detachable area 218 encompassed by the edges of the pad 103 and the cuts 202 made thereon. For smaller wounds, detachable areas 212a, 212b, 214a, and 214b may all be removed to leave only the detachable areas 216 and 217. In even smaller wounds, the remainder of the pad 103 may be removed to leave only the central detachable area 216. Typically, such sizing can be performed manually, for example using scissors, but such methods incur concomitant disadvantages such as difficulties in manipulating a cutting utensil in a busy operating room, uneven and imprecise cuts, and the possibility of shedding foreign particles into a wound site. Instead, the premade cuts on the pad 103 may be detached by hand or with minimal cutting along the various bridge portions 206, 220, 222.
With continued reference to
The wound contact layer 105 is preferably larger than the foam pad 103, because when used, the wound contact layer 105 may then be tucked around and into a wound site. For example, when used in an abdominal wound, the wound contact layer 105 is preferably inserted into the abdominal cavity between the bowels. Preferably, the wound contact layer 105 is arranged so as to prevent the pad 103 from contacting abdominal viscera and other internal organs, although contact with the edges of the abdominal incision may be acceptable.
In the course of treatment using the system described above, the wound contact layer 105 is preferably permeable, for example provided with openings such as holes, slits, or channels. These openings may be useful in particular in the treatment of abdominal compartment syndrome, where these openings can be used to channel the often-copious amounts of exudate and other fluids that may be produced. In addition to aiding in the removal of exudate and other fluids from a wound site, the openings are useful for transmitting and distributing negative pressure to the wound site. Preferably, the openings are small enough to prevent the ingrowth of tissue, but large enough to prevent occlusion. Additionally, some embodiments of the wound contact layer 105 can be provided with a microperforated wound contact layer. Different embodiments of the wound contact layer 105 (for example as illustrated in
Treatment of wounds with negative pressure generally requires that the wound be cleaned in a medically-acceptable manner, optionally filled with a wound packing material of some sort (such as foam), sealed with a drape, and connected to a source of negative pressure. The treatment of wounds exposing internal organs, blood vessels, and nerves, and in particular those in the abdominal cavity, may necessitate particular considerations. First, typical wound packing materials such as foam or gauze may desirably not be placed in direct contact with abdominal viscera such as the intestines or stomach, as these materials may undesirably adhere to the viscera. Instead, a non- or minimally-adherent wound contact layer 105, described previously, is preferably placed in the abdominal cavity or wound site 110. This wound contact layer 105 is preferably cut to size (if necessary), and tucked between the viscera and the abdominal fascia, with any excess material folded up over itself to avoid trapping any of the abdominal contents. Subsequently, the foam pad 103, after being sized as described above, is placed over the wound contact layer and preferably toward the middle of the wound site 110. A drape 107, again as described above, is cut to size (if necessary) and preferably placed such that it overlaps onto at least a portion of healthy skin surrounding the wound site 110. In some cases, if one drape 107 is insufficient, additional drapes may be provided; these are preferably overlapped at least partially so as to permit a secure seal to be made. Preferably, the drape 107 is provided with an adhesive layer on its underside, which may be protected by a backing layer. Such a backing layer is preferably removed before use so as to permit the drape 107 to be adhered to the skin surrounding the wound site as well as to the foam pad 103. An aperture 109 may then be made through the drape 107, although some embodiments may comprise a drape 107 supplied with one or more pre-made aperture or apertures 109. A conduit 112 connected to a source of negative pressure may then be connected to the aperture 109, or, in some embodiments, under a side of the drape 107, such that a fluidic connection between the wound site 110 and the source of negative pressure is created. The fluidic connection permits the therapeutic application of negative pressure to the wound site 110, and may be applied as necessary until the wound site 110 has reached a desired level of healing or until another surgical intervention is required.
Of course, the foregoing description is that of certain features, aspects and advantages of the present invention, to which various changes and modifications can be made without departing from the spirit and scope of the present invention. Moreover, the negative pressure treatment system disclosed herein need not feature all of the objects, advantages, features and aspects discussed above. Those of skill in the art will recognize that the invention can be embodied or carried out in a manner that achieves or optimizes one advantage or a group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein. For example, in some embodiments the pad 103 can be used without the wound contact layer 105 and/or drape 107. In addition, while a number of variations of the invention have been shown and described in detail, other modifications and methods of use, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is contemplated that various combinations or subcombinations of these specific features and aspects of embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the discussed negative pressure treatment system.
This application claims the benefit of U.S. Provisional Application No. 61/308,766, filed Feb. 26, 2010, the entirety of which is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
1066934 | Manney | Jul 1913 | A |
4095599 | Simonet-Haibe | Jun 1978 | A |
4252119 | Coates | Feb 1981 | A |
4341207 | Steer et al. | Jul 1982 | A |
4360015 | Mayer | Nov 1982 | A |
4360021 | Stima | Nov 1982 | A |
4499896 | Heinecke | Feb 1985 | A |
4561435 | McKnight et al. | Dec 1985 | A |
4699134 | Samuelsen | Oct 1987 | A |
4759354 | Quarfoot | Jul 1988 | A |
4798603 | Meyer et al. | Jan 1989 | A |
4867150 | Gilbert | Sep 1989 | A |
4875473 | Alvarez | Oct 1989 | A |
4882213 | Gaddis et al. | Nov 1989 | A |
4969880 | Zamierowski | Nov 1990 | A |
4997425 | Shioya et al. | Mar 1991 | A |
5080661 | Lavender et al. | Jan 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5218973 | Weaver et al. | Jun 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5264218 | Rogozinski | Nov 1993 | A |
5322695 | Shah et al. | Jun 1994 | A |
5336209 | Porzilli | Aug 1994 | A |
5445604 | Lang | Aug 1995 | A |
5486158 | Samuelson | Jan 1996 | A |
5496605 | Augst et al. | Mar 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5593395 | Martz | Jan 1997 | A |
5599289 | Castellana | Feb 1997 | A |
5616387 | Augst et al. | Apr 1997 | A |
5633007 | Webb et al. | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5681579 | Freeman | Oct 1997 | A |
5713881 | Rezai et al. | Feb 1998 | A |
5714225 | Hansen et al. | Feb 1998 | A |
5733305 | Fleischmann | Mar 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5792090 | Ladin | Aug 1998 | A |
5810755 | LeVeen et al. | Sep 1998 | A |
D403774 | Laughlin et al. | Jan 1999 | S |
5885237 | Kadash et al. | Mar 1999 | A |
D408920 | Dunshee et al. | Apr 1999 | S |
5899893 | Dyer et al. | May 1999 | A |
5958420 | Jenson | Sep 1999 | A |
D415836 | Dunshee et al. | Oct 1999 | S |
5981822 | Addison | Nov 1999 | A |
5985990 | Kantner et al. | Nov 1999 | A |
6071267 | Zamierowski | Jun 2000 | A |
6087549 | Flick | Jul 2000 | A |
6117111 | Fleischmann | Sep 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6203563 | Fernandez | Mar 2001 | B1 |
6293281 | Shultz et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6350339 | Sessions | Feb 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6458109 | Henley | Oct 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6680113 | Lucast et al. | Jan 2004 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6794554 | Sessions et al. | Sep 2004 | B2 |
6797855 | Worthley | Sep 2004 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6838589 | Liedtke et al. | Jan 2005 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
D506547 | Cruz et al. | Jun 2005 | S |
6951553 | Bubb et al. | Oct 2005 | B2 |
6974428 | Knutson et al. | Dec 2005 | B2 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7005556 | Becker et al. | Feb 2006 | B1 |
7030288 | Liedtke et al. | Apr 2006 | B2 |
7041868 | Greene et al. | May 2006 | B2 |
7137968 | Burrell et al. | Nov 2006 | B1 |
D537948 | Smith | Mar 2007 | S |
D544607 | Henry et al. | Jun 2007 | S |
7291762 | Flick | Nov 2007 | B2 |
7335809 | Riesinger | Feb 2008 | B2 |
7338482 | Lockwood et al. | Mar 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7518031 | Liedtke et al. | Apr 2009 | B2 |
7645269 | Zamierowski | Jan 2010 | B2 |
D620122 | Cotton | Jul 2010 | S |
D620123 | Igwebuike | Jul 2010 | S |
7790946 | Mulligan | Sep 2010 | B2 |
7794438 | Henley et al. | Sep 2010 | B2 |
D639441 | Sferle | Jun 2011 | S |
D644330 | Pfeiffer et al. | Aug 2011 | S |
RE43195 | Cotton | Feb 2012 | E |
20010027285 | Heinecke et al. | Oct 2001 | A1 |
20010034499 | Sessions et al. | Oct 2001 | A1 |
20020065494 | Lockwood et al. | May 2002 | A1 |
20020082567 | Lockwood et al. | Jun 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20040006319 | Lina et al. | Jan 2004 | A1 |
20040064111 | Lockwood et al. | Apr 2004 | A1 |
20040162512 | Liedtke et al. | Aug 2004 | A1 |
20050113733 | Liedtke et al. | May 2005 | A1 |
20050131327 | Lockwood et al. | Jun 2005 | A1 |
20050143697 | Riesinger | Jun 2005 | A1 |
20050181163 | Kose | Aug 2005 | A1 |
20060041247 | Petrosenko et al. | Feb 2006 | A1 |
20060142687 | Liedtke et al. | Jun 2006 | A1 |
20060178608 | Stapf | Aug 2006 | A1 |
20060241689 | Leiboff et al. | Oct 2006 | A1 |
20070142761 | Aali | Jun 2007 | A1 |
20080095979 | Hatanaka et al. | Apr 2008 | A1 |
20080213344 | McCarthy et al. | Sep 2008 | A1 |
20080243044 | Hunt et al. | Oct 2008 | A1 |
20090099519 | Kaplan | Apr 2009 | A1 |
20090130186 | McCarthy et al. | May 2009 | A1 |
20090177136 | Liedtke et al. | Jul 2009 | A1 |
20090227969 | Jaeb et al. | Sep 2009 | A1 |
20090240185 | Jaeb et al. | Sep 2009 | A1 |
20100069829 | Hutchinson et al. | Mar 2010 | A1 |
20100069858 | Olson | Mar 2010 | A1 |
20100069885 | Stevenson et al. | Mar 2010 | A1 |
20100100022 | Greener et al. | Apr 2010 | A1 |
20100106115 | Hardman et al. | Apr 2010 | A1 |
20100106117 | Lockwood et al. | Apr 2010 | A1 |
20110178451 | Robinson et al. | Jul 2011 | A1 |
Number | Date | Country |
---|---|---|
3539533 | May 1987 | DE |
0122085 | Jun 1987 | EP |
0418607 | Mar 1991 | EP |
0485657 | May 1992 | EP |
0617938 | Mar 1994 | EP |
0638301 | Feb 1995 | EP |
0670705 | Sep 1995 | EP |
465601 | Jan 1997 | EP |
0762860 | Dec 1997 | EP |
0651983 | Sep 1998 | EP |
777504 | Oct 1998 | EP |
688189 | Sep 2000 | EP |
865304 | Jul 2001 | EP |
0875222 | Jul 2002 | EP |
853950 | Oct 2002 | EP |
1513478 | Apr 2003 | EP |
1088569 | Aug 2003 | EP |
1219311 | Jul 2004 | EP |
1018967 | Aug 2004 | EP |
1440667 | Mar 2006 | EP |
1284777 | Apr 2006 | EP |
620720 | Nov 2006 | EP |
1772160 | Jun 2009 | EP |
2 214 728 | Aug 2010 | EP |
1063066 | Mar 1967 | GB |
2085305 | Jan 1985 | GB |
2329127 | Mar 1999 | GB |
2305610 | Jul 1999 | GB |
2357286 | Nov 2003 | GB |
2389794 | Dec 2003 | GB |
2365350 | Aug 2004 | GB |
2423019 | Aug 2006 | GB |
WO 9213713 | Aug 1992 | WO |
WO 9300056 | Jan 1993 | WO |
WO 9420041 | Sep 1994 | WO |
WO 9624316 | Aug 1996 | WO |
WO 9743991 | Nov 1997 | WO |
WO 9838955 | Sep 1998 | WO |
WO 0007653 | Feb 2000 | WO |
WO 0061206 | Oct 2000 | WO |
WO 0149233 | Jul 2001 | WO |
WO 0185248 | Nov 2001 | WO |
WO 0205737 | Jan 2002 | WO |
WO 0226180 | Apr 2002 | WO |
WO 0239940 | May 2002 | WO |
WO 0241878 | May 2002 | WO |
WO 0245761 | Jun 2002 | WO |
WO 02091965 | Nov 2002 | WO |
WO 03086232 | Oct 2003 | WO |
WO 2004018020 | Mar 2004 | WO |
WO 2005009488 | Feb 2005 | WO |
WO 2006130594 | Dec 2006 | WO |
WO 2007075379 | Jul 2007 | WO |
WO 2008039839 | Apr 2008 | WO |
WO 2008040681 | Apr 2008 | WO |
WO 2008064503 | Jun 2008 | WO |
WO 2008104609 | Sep 2008 | WO |
WO 2009011856 | Jan 2009 | WO |
WO 2009021523 | Feb 2009 | WO |
WO 2009070905 | Jun 2009 | WO |
WO 2010016791 | Feb 2010 | WO |
WO 2010033271 | Mar 2010 | WO |
WO 2010033574 | Mar 2010 | WO |
WO 2010033613 | Mar 2010 | WO |
WO 2010051068 | May 2010 | WO |
WO 2010051073 | May 2010 | WO |
WO 2010072309 | Jul 2010 | WO |
WO 2011106722 | Sep 2011 | WO |
WO 2012138514 | Oct 2012 | WO |
Entry |
---|
U.S. Appl. No. 29/363,038, filed Jun. 3, 2010, Lattimore et al. |
Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” in current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvashia State University, Cheboksary, USSR 1986) pp. 94-96. |
Barker et al., “Vacuum Pack Technique of Temporary Abdominal Closure”; J. of Traumatic Injury, Infection, and Critical Care, vol. 48, No. 2 (2000). |
Brock, W.B., et al.: “Temporary closure of open abdominal wounds: the vacuum pack”, Am. Surg. Jan. 1995; 61(1)30-5—abstract. |
Fleischmann et al., “Vacuum sealing for treatment of soft tissue damage in open fractures,” Der Unfallchirurg 1993;96(9):488-92. |
Garner et al., “Vacuum-assisted wound closure provides early fascial reapproximation in trauma patients with open abdomens,” Am. J. of Surgery 1282 (2001) 630-638. |
Harris, “A new technique of skin grafting using Stei-Greffe and a self-adhering foam pad,” Brit. J. of Plastic Surg., vol. 34, No. 2, (Apr. 1981), pp. 181-185. |
“Hydrocolloids,” J. of Wound Care, vol. 1, No. 2, (Jul.-Aug. 1992), pp. 27-30. |
Jeter, K. “Managing Draining Wounds and Fistulae: New and Established Methods” Chronic Wound Care pp. 240-246, 1990. |
KCI Licensing, “V.A.C. Abdominal Dressing System Advanced Management of the Open Abdomen,” 2004. |
Navsaria, et al.: “Temporary closure of open abdominal wounds by the modified sandwich-vacuum pack technique”, British Journal of Surgery 2003; 90: 718-722. |
Nicholas, J.M., Options for Management of the Open Abdomen, Presentation from Emory University School of Medicine, 66 pgs. Invited Speaker American College of Surgeons 32nd Annual Spring Meeting, General Session 12—Presentation and Panel Discussion on The Open Abdomen in General Surgery—How Do You Close the Abdomen When You Can't—Boston Marriott Copley Place Hotel, Boston, MA Apr. 26, 2004. |
Orgill, D.P., et al., Guidelines for Treatment of Complex Chest Wounds with Negative Pressure Wound Therapy, Wounds, A Compendium of Clinical Research and Practice, Suppl. B, Dec. 2004, 1-23. |
Schein et al., “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery, 1986, vol. 73, May, pp. 369-370. |
Smith, et al.; Vacuum Pack Technique of Temporary Abdominal Closure: A Four-Year Experience; The American Surgeon; Dec. 1997; p. 1102-1108; vol. 63, No. 12. |
Solovev, V.A. “Treatment and Prevention of Suture Failures after Gastric Resection” (Dissertation Abstract) (S.M. Kirov Gorky State Medical Institute, Gorky USSR 1988). |
International Search Report and Written Opinion for International Application No. PCT/US2011/026347 mailed Jun. 6, 2011. |
KCI V.A.C. Simplace Dressing Brochure 2008, in 2 pages. |
International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2011/026347 (published WO 2011/106722), issued Aug. 28, 2012. |
Number | Date | Country | |
---|---|---|---|
20110213287 A1 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
61308766 | Feb 2010 | US |